Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantationArie Regev, Enrique Molina, Rosana Moura, et al.Annals of Surgery|July 3, 2026
Revisiting Simultaneous Liver and Kidney Transplantation from Donors After Circulatory Death in the Era of Machine Perfusion Technologies: A US Nationwide Analysis of 10,687 CasesJiro Kusakabe, Eduardo Fernandes, Kalyan Ram Bhamidimarri, et al.Optics Express|September 22, 2011
Low propagation loss silicon-on-sapphire waveguides for the mid-infraredFangxin Li, Stuart D Jackson, Christian Grillet, et al.Clinical Nuclear Medicine|August 1, 2024
Performance and Interpretation of Lung Scintigraphy: An Evaluation of Current Practices in Australia, Canada, France, Germany, and United StatesRomain Le Pennec, Wolfgang Schaefer, Mark Tulchinsky, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infectionJonathan Zalevsky, Thomas Secher, Sergei A Ezhevsky, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|November 30, 2016
Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY studyJacqueline G O'Leary, Robert J Fontana, Kimberly Brown, et al.The Laryngoscope|June 29, 2019
Pediatric tracheostomy: A large single-center experienceJessica Roberts, Jason Powell, Jacob Begbie, et al.Journal of Crohn'S & Colitis|March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's DiseaseMatthieu Allez, Bruce E Sands, Brian G Feagan, et al.Journal of Hepatology|April 7, 2009
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BStefan Zeuzem, Edward Gane, Yun-Fan Liaw, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 17, 2023
Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single-center experienceAnmary A Fernandez, Jacques Simkins, Shweta Anjan, et al.Pageof 7